Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.52 EUR | -1.37% |
|
-4.14% | -33.71% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Highlights